C-Reactive Protein Versus Hemogram-Derived Inflammatory Indices in Infants Evaluated for Hemodynamically Significant Patent Ductus Arteriosus
Background: Ductal patency in preterm infants is partly inflammation-driven, and hemogram-derived systemic inflammatory indices have been proposed as accessible markers of a hemodynamically significant patent ductus arteriosus (hsPDA). Whether these indices carry information beyond gestational age and routinely measured C-reactive protein (CRP), and whether their temporal trajectory differs in hsPDA, are unknown, particularly in real-world cohorts evaluated for hsPDA across a broad gestational-age range. Methods: In this single-center retrospective cohort, 79 infants of 24–40 weeks’ gestation (including 10 born at term) undergoing echocardiographic evaluation of the ductus (December 2024–July 2026) had complete blood counts and CRP at two predefined windows (0–48 h and 48–120 h). Six indices (NLR, PLR, MLR, SII, SIRI, PIV) and their between-sampling change were compared by hsPDA status (diameter ≥ 1.5 mm, LA/Ao > 1.4, unrestrictive left-to-right flow), with Benjamini–Hochberg correction, ROC analysis, and gestational-age-adjusted logistic models including CRP. Results: Thirty-six infants (45.6%) had hsPDA. No first-sample index differed between groups (all p > 0.7; AUC 0.48–0.51). At the second sampling, NLR (p = 0.009), SIRI (p = 0.007), and MLR (p = 0.031) were higher in hsPDA, as was the between-sampling change in MLR (ΔMLR, p = 0.006); however, no index remained significant after multiplicity correction (smallest q = 0.057), and none of these differences persisted in samples drawn before treatment. Second-sample CRP was the strongest discriminator (AUC 0.894, 95% CI 0.815–0.960). After adjustment for gestational age and surfactant therapy (Firth regression), CRP remained independently associated with hsPDA (OR 1.91 per doubling, 95% CI 1.47–2.68), whereas MLR did not (OR 1.07 per SD, 95% CI 0.60–2.44). Conclusions: In infants of mixed gestational age evaluated for ductal patency, CRP measured around the time of diagnosis discriminated hsPDA better than all six hemogram-derived indices, which carried no information independent of CRP or respiratory illness severity. CRP rose concurrently with, rather than ahead of, hemodynamic significance, and its signal lay largely at the low end of the measurable range; neither CRP nor the indices should be regarded as predictors of hsPDA.
Authors
- Özhan Orhan (ORCID: https://orcid.org/0000-0002-3042-6972)
- Yusuf Alakaş (ORCID: https://orcid.org/0000-0002-9936-8184)
- Mehmet Nur Talay (ORCID: https://orcid.org/0000-0002-7361-3823)
- Ali Nazım Güzelbağ (ORCID: https://orcid.org/0000-0003-3314-9090)
- Adnan Azizoğlu (ORCID: https://orcid.org/0009-0002-6651-7873)
- Muhammet Hocaoğlu
- Eylem Sezgen Unay
- Lokman Timurağaoğlu
Institutions
- Mardin Artuklu University (TR)
Publication Details
- Journal
- Journal of Cardiovascular Development and Disease
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3390/jcdd13110602
- Primary Topic
- Cardiovascular Conditions and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00